Scientists unveil ‘Rosetta Stone’ of prostate cancer
21 May 2015 | By Victoria White
Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs...
List view / Grid view
News
Re-engineered spectinomycin shows potential for treatment of drug-resistant bacteria
21 May 2015 | By Victoria White
Researchers have developed a second-generation of spectinomycin that shows early effectiveness against common bacterial infections...
Alnylam files Clinical Trial Application for ALN-AAT for the treatment of Alpha-1 Liver Disease
21 May 2015 | By Victoria White
Alnylam has filed a Clinical Trial Application to initiate a Phase 1/2 clinical trial with ALN-AAT for the treatment of alpha-1 liver disease...
Orphan Drug Designation granted in the EU for ISTH0036 to treat advanced-stage glaucoma
21 May 2015 | By Victoria White
The EMA has granted orphan drug designation for ISTH0036, a locked nucleic acid-modified antisense oligonucleotide, to treat advanced-stage glaucoma...
First cancer-promoting oncogenes discovered in choroid plexus carcinoma
21 May 2015 | By Victoria White
Researchers have identified three genes that play a pivotal role in choroid plexus carcinoma, a discovery that could lead to more effective treatment...
Zealand starts clinical development of a multiple-dose version of ZP4207
20 May 2015 | By Victoria White
Zealand has advanced a multiple-dose version of ZP4207 into clinical development for the treatment of mild to moderate hypoglycaemia in diabetes patients...
Ipsen signs agreement to acquire Octreopharm Sciences
20 May 2015 | By Victoria White
Ipsen signed an agreement to acquire OctreoPharm Sciences, a life sciences company focusing on the development of innovative radioactive labelled compounds...
Mucosis to present data on intranasal RSV vaccine SynGEM at MVADS 2015
19 May 2015 | By Victoria White
Dr Leenhouts is set to discuss the progress with Mucosis' intranasal respiratory syncytial virus (RSV) vaccine candidate, SynGEM, at MVADS 2015...
Genmab and BioNTech sign co-development agreement in immuno-oncology
19 May 2015 | By Victoria White
BioNTech has signed an agreement with Genmab to jointly research, develop and commercialise multiple bispecific antibodies for cancer immunotherapy...
Scientists discover why Streptococcus pneumoniae infections can cause fatal heart complications
19 May 2015 | By Victoria White
Researchers have discovered a key cause of life threatening heart complications, conditions that frequently follow severe Streptococcus pneumoniae infection..
Broad Institute receives $10 million from the Gerstner Family Foundation to research cancer drug resistance
18 May 2015 | By Victoria White
Broad Institute of MIT and Harvard are to receive a $10 million gift from the Gerstner Family Foundation that will expand cancer research...
Anavex releases preclinical anti-seizure data for ANAVEX 2-73
18 May 2015 | By Victoria White
Anavex revealed full preclinical anti-seizure data for its lead drug candidate, ANAVEX 2-73, at the Antiepileptic Drug Trials XIII Conference...
Ablynx and Genzyme to collaborate on multiple sclerosis research project
18 May 2015 | By Victoria White
Ablynx is set to collaborate with Genzyme to investigate Nanobodies against a target that plays an important role in multiple sclerosis (MS)...
Contraceptive and cholesterol-lowering drug combination (BaP) used to treat cancer
15 May 2015 | By Victoria White
The BaP combination of a cholesterol-lowering drug, bezafibrate and a contraceptive steroid could be an effective treatment for a range of cancers.
Lilly and Sanford-Burnham to collaborate to discover immunological therapies
15 May 2015 | By Victoria White
Eli Lilly and Company and Sanford-Burnham Medical Research Institute are to collaborate to discover and develop immunological therapies...